⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31591139 | 1.00 | ALDH1A1 (0.37) | — | |
| SCHEMBL29052233 | 1.00 | ALDH1A1 (0.37) | — | |
| Methane SCHEMBL28946775 | 0.97 | — | — | |
| SCHEMBL30776079 | 0.92 | ALDH1A1 (0.32) | — | |
| SCHEMBL9120653 | 0.92 | CHRM2 (0.33) | — | |
| SCHEMBL3409130 | 0.89 | TDP1 (0.48) | — | |
| SCHEMBL200065 | 0.88 | — | — | |
| SCHEMBL2300507 | 0.88 | — | — | |
| SCHEMBL8681009 | 0.88 | — | — | |
| SCHEMBL29236516 | 0.87 | CYP1A2 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0271180-B2 | Starburst conjugates | DOW CHEMICAL CO (US) | 1997-06-18 | — | — | EP | claimed |
| US-5527524-A | AGRICULTURAL, PHARMACEUTICAL, DRUG DELIVERY | THE DOW CHEMICAL COMPANY (US) | 1996-06-18 | — | — | US | claimed |
| WO-1988001178-A1 | STARBURST CONJUGATES | THE DOW CHEMICAL COMPANY (US) | 1988-02-25 | — | — | WO | claimed |
| WO-2023151942-A1 | DEVICE FOR CONVERTING THERMAL ENERGY OF AN EXTERNAL HEAT SOURCE INTO ELECTRICAL ENERGY | HAESE FRANK (DE) | 2023-08-17 | — | — | WO | disclosed |
| EP-4227604-A1 | DEVICE FOR CONVERTING THERMAL ENERGY OF AN EXTERNAL HEAT SOURCE INTO ELECTRICAL ENERGY | Haese, Frank (DE) | 2023-08-16 | — | — | EP | disclosed |
| CN-115650892-A | Method for preparing carbon-acyloxy substituted aziridine compound | 潍坊科技学院 | 2023-01-31 | — | — | CN | disclosed |
| CN-102154667-A | Anti-displacement hard gold compositions | ROHM & HAAS ELECT MAT | 2011-08-17 | — | — | CN | disclosed |
| US-6503898-B1 | Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-01-07 | — | — | US | disclosed |
| US-RE37781-E1 | VIRICIDES, PROTEASE INHIBITOR | DUPONT PHARMACEUTICALS COMPANY | 2002-07-02 | — | — | US | disclosed |
| EP-1153921-A2 | Cyclic ureas and analogues useful as retroviral protease inhibitors | Dupont Pharmaceuticals Company (US) | 2001-11-14 | — | — | EP | disclosed |
| US-5811422-A | USEFUL FOR TREATING VIRAL INFECTIONS | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0607334-B1 | CYCLIC UREAS AND ANALOGUES USEFUL AS RETROVIRAL PROTEASE INHIBITIORS | DU PONT MERCK PHARMA (US) | 1997-07-30 | — | — | EP | disclosed |
| EP-0765873-A1 | Cyclic ureas and analogues useful as retroviral protease inhibitors | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-04-02 | — | — | EP | disclosed |
| US-5610294-A | VIRAL TREATMENT | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-03-11 | — | — | US | disclosed |
| EP-0607334-A1 | CYCLIC UREAS AND ANALOGUES USEFUL AS RETROVIRAL PROTEASE INHIBITIORS. | DU PONT MERCK PHARMA (US) | 1994-07-27 | — | — | EP | disclosed |
| WO-1993007128-A1 | CYCLIC UREAS AND ANALOGUES USEFUL AS RETROVIRAL PROTEASE INHIBITIORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-04-15 | — | — | WO | disclosed |
| US-4337103-A | FUNCTIONALLY TERMINATED RUBBER | HERCULES INCORPORATED (US) | 1982-06-29 | — | — | US | disclosed |